215 reports of this reaction
1.5% of all GUANFACINE reports
#14 most reported adverse reaction
ABNORMAL BEHAVIOUR is the #14 most commonly reported adverse reaction for GUANFACINE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 215 FDA adverse event reports linking GUANFACINE to ABNORMAL BEHAVIOUR. This represents approximately 1.5% of all 13,968 adverse event reports for this drug.
Patients taking GUANFACINE who experience abnormal behaviour should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABNORMAL BEHAVIOUR is a less commonly reported adverse event for GUANFACINE, but still significant enough to appear in the safety profile.
In addition to abnormal behaviour, the following adverse reactions have been reported for GUANFACINE:
The following drugs have also been linked to abnormal behaviour in FDA adverse event reports:
ABNORMAL BEHAVIOUR has been reported as an adverse event in 215 FDA reports for GUANFACINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABNORMAL BEHAVIOUR accounts for approximately 1.5% of all adverse event reports for GUANFACINE, making it a notable side effect.
If you experience abnormal behaviour while taking GUANFACINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.